SCHEMBL2302192

SCHEMBL2302192

O=C(c1ccc(-c2cc(Cl)c(CN3CC[C@@H](C4CCCCC4)C3=O)c(Cl)c2)cc1)N1CCN(CCF)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.41
HTT P42858 1/20 0.39
PDE5A O76074 1/20 0.38
PDE4A P27815 1/20 0.38
PDE1A P54750 1/20 0.38
PDE1B Q01064 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE7A Q13946 1/20 0.38
PDE1C Q14123 1/20 0.38
PDE3A Q14432 1/20 0.38
PDE7B Q9NP56 1/20 0.38
HRH3 Q9Y5N1 7/20 0.37
KCNH2 Q12809 1/20 0.37
PER2 O15055 2/20 0.37
LSS P48449 1/20 0.37
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 2/20 0.35
FASN P49327 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2021298 1.00 CHKA (0.41) CHKAHTTPDE5APDE4APDE1A
SCHEMBL2296908 1.00 CHKA (0.41) CHKAHTTPDE5APDE4APDE1A
Hydrochloric Acid SCHEMBL2300289 0.99 HTT (0.41) CHKAHTTPDE5APDE4APDE1A
Hydrochloric Acid SCHEMBL2300283 0.99 HTT (0.41) CHKAHTTPDE5APDE4APDE1A
SCHEMBL2025544 0.86 CHKA (0.37) CHKAHTTPDE5APDE4APDE1A
SCHEMBL2827708 0.86 CHKA (0.37) CHKAHTTPDE5APDE4APDE1A
SCHEMBL2303903 0.86 PKM (0.45) HRH3KMT2AGAAHPGD
SCHEMBL2296932 0.85 SPR (0.37) PDE5APDE4APDE1APDE1BPDE4B
SCHEMBL2301464 0.85 HRH3 (0.49) PDE5APDE4APDE1APDE1BPDE4B
SCHEMBL13513407 0.83 HRH3 (0.41) CHKAPDE5APDE4APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7994176-B2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2011-08-09 US claimed
EP-2021337-B1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2010-01-13 EP claimed
US-20090099182-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-04-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099182-A1 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD11B2, HSD3B1 CHKA 1807/4885HTT 3383/4885PDE5A 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.